<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BBA8EF7-8C5F-4BF2-96CB-6A66D0CBD157"><gtr:id>5BBA8EF7-8C5F-4BF2-96CB-6A66D0CBD157</gtr:id><gtr:name>University of Illinois at Urbana-Champaign</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1E3015FF-23BB-4B73-8C80-84C53F33B745"><gtr:id>1E3015FF-23BB-4B73-8C80-84C53F33B745</gtr:id><gtr:name>Hospital for Sick Children, Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BBA8EF7-8C5F-4BF2-96CB-6A66D0CBD157"><gtr:id>5BBA8EF7-8C5F-4BF2-96CB-6A66D0CBD157</gtr:id><gtr:name>University of Illinois at Urbana-Champaign</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1E3015FF-23BB-4B73-8C80-84C53F33B745"><gtr:id>1E3015FF-23BB-4B73-8C80-84C53F33B745</gtr:id><gtr:name>Hospital for Sick Children, Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5B860B10-381A-4E49-B49F-D740AFA8F3A5"><gtr:id>5B860B10-381A-4E49-B49F-D740AFA8F3A5</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:otherNames>Anton</gtr:otherNames><gtr:surname>van der Merwe</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G19%2F31"><gtr:id>97E91885-961D-4FE2-A448-B14AE3C3D0CF</gtr:id><gtr:title>MRC Non-Clinical Readership</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G19/31</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>T cells control both the cellular and humoral immune responses, and T cell function is in turn controlled by antigen recognition. T cell antigen recognition (TCAR) is therefore the key to understanding allergy, autoimmunity, allograft rejection, immunity to infection and vaccination. This programme focuses on events at the T cell surface, where antigen recognition occurs and where it is most amenable to therapeutic manipulation. TCAR occurs in an area of contact between a T cell and another cell. The basic features of molecular recognition at the cell surface are poorly understood. The FIRST major objective of this proposal is a structural, biochemical, and biophysical analysis of the interactions of the T cell antigen receptor (TCR) as well as several T cell-restricted cell-cell recognition molecules (CD2, CD4, CD8, CD28, and CTLA-4) which modulate TCAR. The interactions of soluble forms of these molecules with their respective ligands will be analyzed mainly by surface plasmon resonance and titration microcalorimetry, both of which are well suited to measuring weak molecular interactions. In order to gain insight into molecular properties relevant to cell-cell recognition, the interaction of membrane-associated forms of these molecules will be studied using the surface force apparatus and a novel planar lipid bilayer/fluorescent imaging technique. Detailed knowledge of these molecular interactions will complement ongoing structural studies and facilitate the development of rational models of TCAR. This is the SECOND major objective of the proposal. We have proposed a novel segregation model of TCR triggering which takes into account the dimensions of the molecules involved and the kinetics of their interactions. An easily manipulated in vitro system of TCAR will be used to test and refine this model. Where necessary, in vivo studies will be undertaken to confirm and extend this work using genetically manipulated mice.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>232436</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>U600</gtr:department><gtr:description>Measuring the 2D binding and mechanical properties of TCR/pMHC interaction</gtr:description><gtr:id>804D4F37-5CB9-4AF6-AF39-1A7E5812E1D7</gtr:id><gtr:impact>Publication in press Philippe Robert et al (2011)</gtr:impact><gtr:outcomeId>Fi3yMPmk6We-1</gtr:outcomeId><gtr:partnerContribution>They provided the equipment and specific expertise</gtr:partnerContribution><gtr:piContribution>We initiated the projects, provided reagents, and designed experiments, which were performed in their laboratory using their bead flow system</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Immunology and Inflammation</gtr:department><gtr:description>Importance of pMHC dimension in TCR recognition</gtr:description><gtr:id>35722BD2-193F-4E8E-90C0-9F8B102D15F4</gtr:id><gtr:impact>19342630 19628870 20432238</gtr:impact><gtr:outcomeId>93D24A68928-1</gtr:outcomeId><gtr:partnerContribution>They helped with the design and production of single chain forms of peptide MHC class I molecules</gtr:partnerContribution><gtr:piContribution>We designed the contructs and performed functional experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mathematical modelling of T cell receptor triggering</gtr:description><gtr:id>79DEF672-5A5D-4123-83A1-8A905D024C42</gtr:id><gtr:impact>16751250 17367335</gtr:impact><gtr:outcomeId>D14D7D73AAD-1</gtr:outcomeId><gtr:partnerContribution>The have helped with mathematical modelling</gtr:partnerContribution><gtr:piContribution>We helped them to develop a mathematical model of T cell receptor triggering</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Immunology Unit</gtr:department><gtr:description>T cell surface molecule structure/function studies</gtr:description><gtr:id>B8A5030D-DEC6-4E27-8812-6687B4C483A8</gtr:id><gtr:impact>16388312 18275829 19303388 17485514 16803907 20137987 20053942</gtr:impact><gtr:outcomeId>9719D0F2401-1</gtr:outcomeId><gtr:partnerContribution>Typically they provide a source of human T cell clones and T cell receptors derived from these. In addition they have clinical and functional data.</gtr:partnerContribution><gtr:piContribution>We perform detailed kinetic and thermodynamic studies of TCR/pMHC interactions and correlate these with functional effects</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Illinois at Urbana-Champaign</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Analysis of mechanical properites of CD2/CD58 interacation</gtr:description><gtr:id>A8EB5913-8D50-4D4B-9B79-51FCF484C64C</gtr:id><gtr:impact>17172599</gtr:impact><gtr:outcomeId>884D89BB979-1</gtr:outcomeId><gtr:partnerContribution>They assisted with mechanical analysis using the surface force apparatus</gtr:partnerContribution><gtr:piContribution>We conceived of the experiments, produced a series of mutant proteins, performed kinetic and thermodynamic studies and assisted with the SFA measurments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>New York University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Testing the effect of CD48 elongation in planar bilayers</gtr:description><gtr:id>7A619026-1421-4A8B-BCFE-F1E50AC373E3</gtr:id><gtr:impact>18826951</gtr:impact><gtr:outcomeId>F5A1F96B7A5-1</gtr:outcomeId><gtr:partnerContribution>The provided expertise and performed experiments using reconstituted planar lipid bilayers</gtr:partnerContribution><gtr:piContribution>We conceived of the experiment and produced, characterised and supplied the key reagents that they studied in their planar bilayer system.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital for Sick Children, Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Role of CD45 ectodomains in phagocytic synapse</gtr:description><gtr:id>784FEA4D-883B-4FC7-A8CA-15980A66F73A</gtr:id><gtr:impact>One publication so far in a high impact journal. Freeman et al 2016</gtr:impact><gtr:outcomeId>56bcbad6293494.84792624-1</gtr:outcomeId><gtr:partnerContribution>Most of the actual experiments were performed by them with us providing reagents and advice, and assisting with designs and interpretation of experiments.</gtr:partnerContribution><gtr:piContribution>Our contribution was to advise them and assist them with experiments investigation macrophage phagocytosis. Specifically we helped them demonstrate the role of the CD45 ectodomain in mediating its exclusions from the phagocytic synapse.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>Structure of cell surface molecules</gtr:description><gtr:id>0A8CCD47-D74B-4523-B382-34837D02AEB0</gtr:id><gtr:impact>17761881 16456543</gtr:impact><gtr:outcomeId>0E4BC82BEF1-1</gtr:outcomeId><gtr:partnerContribution>Performs structural studies which complement our binding and imaging studies</gtr:partnerContribution><gtr:piContribution>Typically we perform binding, mutagenesis and imaging studies to complement their structural studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>599B1903-E03D-4C92-9665-61AA44EC6D3A</gtr:id><gtr:impact>Attended local primary school and spoke on infection by viruses

Resulted in follow up visits</gtr:impact><gtr:outcomeId>98CA7154137</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>House of Commons</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D335E3FF-5CA1-463D-80FC-C2E9312E74AA</gtr:id><gtr:impact>Group member presented poster at Special Reception at the House of Commons for Younger Researchers in Bioscience and Medicine

Considerable interest</gtr:impact><gtr:outcomeId>1EE5DBBAE45</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8BDE699C-6F56-4E2E-A582-22FD8EC57EFC</gtr:id><gtr:impact>Interviewed by journalist on a range of topics relating to the immune system

Resulted in an accurate but accessible article which was widely disseminated</gtr:impact><gtr:outcomeId>4665B19B3C1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>208000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Research Grant</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>B04B712F-73F6-4961-8AE0-C28AD6273CAB</gtr:id><gtr:outcomeId>7349D9052480</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>112000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Research Grant</gtr:description><gtr:end>2008-06-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>84912E7A-0511-4A9D-80EF-D87F542BD1E0</gtr:id><gtr:outcomeId>92BFE954BDF0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>285000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Research UK</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>30384886-0919-437D-A020-B24EF1F6D3B3</gtr:id><gtr:outcomeId>LrUT4JYrXfu0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>409364</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F18815CD-67FB-4F9A-800D-EE76D5908687</gtr:id><gtr:outcomeId>NUHT21vGstp0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigatory Award</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>DD215AE0-1222-45D7-9A2D-E944E64131A2</gtr:id><gtr:outcomeId>GFTvd1dFbef</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have established a Facility for studying molecular interactions using surface plasmon resonance.</gtr:description><gtr:id>962D1BB9-9ED5-4F5E-9CEE-5F2185FF84BF</gtr:id><gtr:impact>Many publications have resulted from data obtained using this facility</gtr:impact><gtr:outcomeId>D97B6EB5D35</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Surface plasmon resonance facility</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E34D9AD6-6400-4926-B94A-72FF123C617F</gtr:id><gtr:title>Mutant prolactin receptor and familial hyperprolactinemia.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4012bab03e044a389467d6bd29325d39"><gtr:id>4012bab03e044a389467d6bd29325d39</gtr:id><gtr:otherNames>Newey PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_13747_27_24195502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0201220F-E062-4A07-84D8-AC41F7B06B1B</gtr:id><gtr:title>Non-catalytic tyrosine-phosphorylated receptors.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2f2bd7f336da8c018723aeaf0de7f58"><gtr:id>f2f2bd7f336da8c018723aeaf0de7f58</gtr:id><gtr:otherNames>Dushek O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>pm_13747_27_23046135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E207355C-4DD8-44BD-ADB5-E712219A5104</gtr:id><gtr:title>An induced rebinding model of antigen discrimination.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2f2bd7f336da8c018723aeaf0de7f58"><gtr:id>f2f2bd7f336da8c018723aeaf0de7f58</gtr:id><gtr:otherNames>Dushek O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>545a724af1f912.14882129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DB645EA-137A-4AEF-B1EE-1FF585F503FD</gtr:id><gtr:title>pyHVis3D: Visualising Molecular Simulation deduced H-bond networks in 3D: Application to T-cell receptor interactions.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89a02323b2c2897dc3ce494840e86b12"><gtr:id>89a02323b2c2897dc3ce494840e86b12</gtr:id><gtr:otherNames>Knapp B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>5a6f2ef1c9af95.36149406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECE053C1-5884-4593-B8EA-3539715BF7D0</gtr:id><gtr:title>Matched sizes of activating and inhibitory receptor/ligand pairs are required for optimal signal integration by human natural killer cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12bda8ce9b1afd7cd41a459f3b3c48b6"><gtr:id>12bda8ce9b1afd7cd41a459f3b3c48b6</gtr:id><gtr:otherNames>K?hler K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13747_27_21179506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5794DD97-9E8F-40A3-BD0D-E772DEF803D2</gtr:id><gtr:title>Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7b1fdce65f189fecec81f703d2dc18"><gtr:id>bb7b1fdce65f189fecec81f703d2dc18</gtr:id><gtr:otherNames>Freeman SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>56bcb8dcbbad22.98294293</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF6F0651-CF48-42F9-95B2-6EC3D93FB833</gtr:id><gtr:title>The contribution of major histocompatibility complex contacts to the affinity and kinetics of T cell receptor binding.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c18098777317.79670345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>443C9F13-4A0A-4AB2-BB9A-2BE2E3503BEB</gtr:id><gtr:title>Architecture of a minimal signaling pathway explains the T-cell response to a 1 million-fold variation in antigen affinity and dose.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe5bd94f53b9b993cc4d1ab8041a832"><gtr:id>fbe5bd94f53b9b993cc4d1ab8041a832</gtr:id><gtr:otherNames>Lever M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c180982a5970.38977286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9BED811-CE0D-4F1D-9D5C-DDF4F8936E37</gtr:id><gtr:title>Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e52e751c5799939489c9ff7b76ec5beb"><gtr:id>e52e751c5799939489c9ff7b76ec5beb</gtr:id><gtr:otherNames>Lim HS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56bcb91ce5c887.29209805</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73DC7867-F244-4B8F-9240-2E663C793E5F</gtr:id><gtr:title>T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74df5c84b51c02bff3ba1fbba395c41a"><gtr:id>74df5c84b51c02bff3ba1fbba395c41a</gtr:id><gtr:otherNames>Brodovitch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5675e0f9e54bf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>450241C9-3871-4AB2-9EA3-A2B5011BFFCD</gtr:id><gtr:title>Ligand dimensions are important in controlling NK-cell responses.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aed47d30abcaa0e82b740e0f85d15cd"><gtr:id>4aed47d30abcaa0e82b740e0f85d15cd</gtr:id><gtr:otherNames>Brzostek J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_13747_27_20432238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43EAF4B2-AA09-4306-862D-B903233E5556</gtr:id><gtr:title>Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/448b5f7fd751cf272bebade77e3e8ec3"><gtr:id>448b5f7fd751cf272bebade77e3e8ec3</gtr:id><gtr:otherNames>Banerji S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58c18098c7f311.09885455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EDB8032-F5E1-417F-AA40-CC61986EDCC9</gtr:id><gtr:title>Phenotypic models of T cell activation.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbe5bd94f53b9b993cc4d1ab8041a832"><gtr:id>fbe5bd94f53b9b993cc4d1ab8041a832</gtr:id><gtr:otherNames>Lever M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>545a724aa30bf9.53079588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>548FDEA5-0AD7-47F7-B7DB-DB652DF3BF07</gtr:id><gtr:title>The large ectodomains of CD45 and CD148 regulate their segregation from and inhibition of ligated T-cell receptor.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256c595bb812967c2c372a7fe586a7ee"><gtr:id>256c595bb812967c2c372a7fe586a7ee</gtr:id><gtr:otherNames>Cordoba SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_13747_27_23580664</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G19/31</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>200</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>200</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>